Synthesis of tritium labelled (3R*, 5S*)-3, 5-dihydroxy-9, 9-diphenyl-6, 8-nonadienoate
- 1 November 1988
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 25 (11) , 1289-1297
- https://doi.org/10.1002/jlcr.2580251116
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Synthesis of 7‐(4′‐fluoro‐3,3′,5‐trimethyl[1,1′‐biphenyl]‐2‐YL)‐3‐hydroxy‐5‐OXO‐5‐13C‐heptanoic acid and trans‐6‐[2‐(4′‐fluoro −3,3′,5‐trimethyl[1,1′‐biphenyl]‐2‐YL)ethyl]‐3,4,5,6‐tetrahydro‐6‐13C‐4‐hydroxy‐2H‐pyran‐2‐oneJournal of Labelled Compounds and Radiopharmaceuticals, 1987
- Inhibitors of Cholesterol Synthesis and CataractsPublished by American Medical Association (AMA) ,1987
- 1,3- diastereoselective reduction of β-hydroxyketones utilizing alkoxydialkylboranesTetrahedron Letters, 1987
- A diastereospecific, non-racemic synthesis of a novel β-hydroxy-δ-lactone HMG-CoA reductase inhibitorTetrahedron Letters, 1985
- Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductaseJournal of Medicinal Chemistry, 1985
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Stereoselective reduction of β hydroxyketones to 1,3-diols highly selective 1,3-asymmetric induction via boron chelatesTetrahedron, 1984